Keloidal scleroderma

Clin Rheumatol. 2004 Feb;23(1):50-1. doi: 10.1007/s10067-003-0823-1. Epub 2003 Dec 18.

Abstract

Progressive systemic sclerosis (PSS) can involve the skin diffusely or in a limited way. Rarely cutaneous involvement can assume a hypertrophic form, described in the literature as keloidal scleroderma. The authors describe a PSS patient who presented cutaneous manifestations compatible with the diagnosis of this clinical situation. The clinical features, pathogenic mechanism and therapeutic approach are discussed and a broad review of the literature is given.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antirheumatic Agents / therapeutic use
  • Azathioprine / therapeutic use
  • Female
  • Humans
  • Keloid / drug therapy
  • Keloid / etiology*
  • Keloid / pathology
  • Penicillamine / therapeutic use
  • Scleroderma, Diffuse / complications*
  • Scleroderma, Diffuse / drug therapy
  • Scleroderma, Diffuse / pathology
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Penicillamine
  • Azathioprine